from journal Cell Stem Cell
Stem cell treatments are becoming more
common in this country. You might think
that is good news, but an article in the
journal Cell Stem Cell reveals that at least
three hundred fifty companies and more
than five hundred individual clinics across
nearly every state are marketing
unapproved stem cell procedures. Most of
these—over three hundred—market
interventions for orthopedic issues,
including sports injuries. Others offer
stem cell treatments for pain, neurological
diseases and even immune disorders. Coauthor
Leigh Turner, of the Center for
Bioethics at the University of Minnesota,
says it appears that regulatory oversight is
minimal. She asks does that mean people
are getting access to safe and effective
treatments or is this basically unapproved
human experimentation?